HealthEdge Partners

View Original

HealthEdge Announces Jon Boumstein and Terry Conrad Join as Operating Partners

Jon Boumstein

Terry Conrad

HealthEdge Announces Jon Boumstein and Terry Conrad Join as Operating Partners

TAMPA, FLORIDA – November 17, 2015 – HealthEdge Investment Partners, LLC (“HealthEdge”), a Tampa, FL healthcare focused investment firm, announced today that Jon Boumstein and Terry Conrad have joined the team as Operating Partners.

Mr. Boumstein currently serves as President and CEO of Fund II portfolio company Data Dimensions, a leading provider of healthcare related business process outsourcing and automation services. Since joining the Company in 1998, Mr. Boumstein has held many executive roles at Data Dimensions, President and Chief Operating Officer. In his current position, Mr. Boumstein is responsible for continuing the innovation, management, and long-term success of Data Dimensions. As a seasoned professional, Mr. Boumstein brings a wealth of industry experience, energy, and extremely creative out-of-the-box thinking.

Mr. Conrad currently serves as CEO of Fund II portfolio company Santus, a skincare products buy and build platform. Mr. Conrad formerly was a member of the Board of Directors of Fund I portfolio company Advanced Bio-Technologies, which was sold to UK-based Sinclair Pharmaceuticals in 2011. Mr. Conrad is a 29 year seasoned executive with a track record of improving shareholder value by making companies more efficient, productive, profitable, and global. Mr. Conrad was most recently the President of the US subsidiary for Photocure, a Norwegian based specialty pharmaceutical firm focused on photodynamic therapies in dermatology and cancer diagnositcs. Prior to that, Mr. Conrad was the President and CEO of Merz Pharmaceuticals’ U.S. division, where he and his team grew annual sales from $20.0 million to $75.0 million through organic growth. Prior to his success at Merz, Mr. Conrad held roles in commercial, business and product development at several large pharmaceutical companies including Parke-Davis, Bayer AG and Lederle Laboratories.

HealthEdge Managing Partner Phil Dingle said, “We are thankful for the addition of talent to our already outstanding team. Jon and Terry are both experienced executives whom we know well with significant domain expertise within healthcare. Like us, they are passionate about healthcare and building businesses.”

About HealthEdge HealthEdge Investment Partners, LLC is an operating-oriented private equity firm founded in 2005 that focuses exclusively on the healthcare industry. HealthEdge seeks to achieve superior returns by investing in businesses that benefit from the knowledge, experience, and network of relationships of its partners. HealthEdge’s partners have more than 100 years of combined operating experience in healthcare as CEOs and investors. For more information on HealthEdge, please visit www.healthedgepartners.com.

For more information, please contact Phil Dingle at HealthEdge Investment Partners at (813) 490-7101.